HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induced posterior vitreous detachment by intravitreal sulfur hexafluoride (SF6) injection in patients with nonproliferative diabetic retinopathy.

AbstractPURPOSE:
To induce posterior vitreous detachment (PVD) in patients with nonproliferative diabetic retinopathy (NPDR) by injecting an intravitreal gas bubble of SF6 and to compare the evolution of the diabetic retinopathy between eyes with gas induced PVD and non-injected eyes without PVD.
METHODS:
An intravitreal gas bubble of SF6 was injected via the pars plana in twelve eyes of twelve patients with NPDR and no previous PVD. Subsequent clinical, ultrasonographic and angiographic controls were performed to evaluate the development of PVD and progression of the disease.
RESULTS:
All gas-injected eyes developed PVD. All eyes with induced PVD (treatment group) remained stable without progression of the retinopathy after 2 years of follow up. In the control group (contralateral eyes without PVD), two eyes (16.6%) progressed to proliferative diabetic retinopathy (PDR) (p= 0.23); five (41.6%) showed progression to more severe stages of NPDR (p= 0.01) and another 41.6% of such eyes remained stable.
CONCLUSIONS:
Intravitreal SF6 injection induced PVD in all eyes of our study without undesirable side effects. Further studies are necessary to make conclusions regarding the correlation between the presence of induced PVD and the progression of diabetic retinopathy.
AuthorsD Ochoa-Contreras, L Delsol-Coronado, M E Buitrago, C Velasco-Barona, H Quiroz-Mercado
JournalActa ophthalmologica Scandinavica (Acta Ophthalmol Scand) Vol. 78 Issue 6 Pg. 687-8 (Dec 2000) ISSN: 1395-3907 [Print] Denmark
PMID11167234 (Publication Type: Journal Article)
Chemical References
  • Sulfur Hexafluoride
Topics
  • Adult
  • Diabetic Retinopathy (physiopathology, prevention & control)
  • Disease Progression
  • Follow-Up Studies
  • Humans
  • Injections
  • Middle Aged
  • Prognosis
  • Sulfur Hexafluoride (administration & dosage)
  • Vitreous Body (drug effects)
  • Vitreous Detachment (chemically induced, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: